Chargement en cours...
The role of third‐generation beta‐blocking agents in chronic heart failure
Third‐generation beta‐blocking agents developed for the hypertension market are proving useful in the treatment of chronic heart failure (HF). These compounds share the ancillary property of vasodilation, which improves acute tolerability by unloading the failing left ventricle at a time when beta‐a...
Enregistré dans:
| Publié dans: | Clin Cardiol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley Periodicals, Inc.
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656140/ https://ncbi.nlm.nih.gov/pubmed/9853189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960211303 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|